English | Español

Biospace
Patient Daily | Apr 10, 2026

Ambrosia Biosciences raises $100 million to develop small-molecule GLP-1 obesity drugs
Patient Daily | Apr 10, 2026

Novo Nordisk to lay off 400 workers at Bloomington plant despite ongoing investment
Patient Daily | Apr 10, 2026

Trump’s MFN pricing expected to delay more European drug launches
Patient Daily | Apr 10, 2026

BioNTech to close Singapore mRNA manufacturing site amid shift in strategy
Patient Daily | Apr 10, 2026

Trump administration imposes 100% tariff on patented drug imports with exemptions
Patient Daily | Apr 10, 2026

Analysts say pharma mergers and acquisitions could reach record levels in 2026
Patient Daily | Apr 10, 2026

FDA approves Eli Lilly’s oral obesity pill Foundayo in April 2026
Patient Daily | Apr 10, 2026

Biotech industry awaits FDA decision on Replimune's RP1 melanoma drug

Trending
+ Marketing
A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’
Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families
+ Regulatory
Patient Daily News Service | Jun 9, 2026

New colon cancer blood test wins Medicare coverage, but trails stool-based screening in detecting precancerous lesions
+ Pharmaceuticals
Patient Daily | Jun 8, 2026

FDA rare disease framework faces uncertainty after leadership departures